Crossmark

Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain

Crossref DOI link: https://doi.org/10.1186/s12881-020-01089-9

Published Online: 2020-08-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Fangjin

Tanaka, Hisashi

Knudsen, Beatrice S. http://orcid.org/0000-0002-7589-7591
Rutgers, Joanne K.
Funding

Funding for this research was provided by:

Prostate Cancer Foundation

National Cancer Institute (R01CA131255)
License Information

Text and Data Mining valid from 2020-08-24

Version of Record valid from 2020-08-24
More Information

Article History

Received: 28 January 2020

Accepted: 8 July 2020

First Online: 24 August 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors do not declare any competing interests.

Document is current

Any future updates will be listed below